TS Financial Group (TSFG)’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 880 |
|
|
2026
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 841 |
|
|
2025
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 839 |
|
|
2025
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 853 |
|
|
2025
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 834 |
|
|
2025
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 823 |
|
|
2024
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 770 |
|
|
2024
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 805 |
|
|
2024
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 776 |
|
|
2024
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 826 |
|
|
2023
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 947 |
|
|
2023
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 944 |
|
|
2023
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 923 |
|
|
2023
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 893 |
|
|
2022
Q4 | $2K | Hold |
17
| – | – | ﹤0.01% | 814 |
|
|
2022
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 883 |
|
|
2022
Q2 | $2K | Hold |
17
| – | – | ﹤0.01% | 794 |
|
|
2022
Q1 | $5K | Hold |
17
| – | – | ﹤0.01% | 644 |
|
|
2021
Q4 | $5K | Hold |
17
| – | – | ﹤0.01% | 661 |
|
|
2021
Q3 | $8K | Hold |
17
| – | – | ﹤0.01% | 586 |
|
|
2021
Q2 | $9K | Hold |
17
| – | – | ﹤0.01% | 565 |
|
|
2021
Q1 | $10K | Buy |
+17
| New | +$11.8K | 0.01% | 488 |
|
Other funds holding GLMD
TS Financial Group (TSFG)'s GLMD Position: Q2 2026 in Review
TS Financial Group (TSFG) held its Galmed Pharmaceuticals (GLMD) position steady in Q2 2026 at 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #880.
TS Financial Group (TSFG) first reported a position in GLMD in Q1 2021 and has held it in 22 quarters since. The position peaked at $10K in Q1 2021. 3 funds tracked by Wall St. Rank hold GLMD as of Q2 2026.
- TS Financial Group (TSFG) held 17 shares of Galmed Pharmaceuticals worth $0 as of Q2 2026.
- TS Financial Group (TSFG) left its Galmed Pharmaceuticals share count unchanged in Q2 2026.
- Galmed Pharmaceuticals made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #880 holding.
- TS Financial Group (TSFG) first reported a position in Galmed Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
- TS Financial Group (TSFG)'s Galmed Pharmaceuticals position peaked at $10K in Q1 2021.
- 3 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2026.
Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.